Fernando Lanas Zanetti

Líneas de investigación

• Factores de riesgo cardiovascular
• Epidemiología de las Enfermedades crónicas
• Terapia en Enfermedades cardiovasculares y diabetes
• Compromiso cardiovascular en COVID-19
• Ensayo clínico de vacuna COVID-10

Tus publicaciones

• CARDIOVERSION IN PATIENTS WITH NEWLY DIAGNOSED NON-VALVULAR ATRIAL FIBRILLATION: OBSERVATIONAL STUDY USING PROSPECTIVELY COLLECTED REGISTRY DATA. Año: 2021
• LATIN AMERICAN CONSENSUS ON MANAGEMENT OF RESIDUAL CARDIOMETABOLIC RISK. A CONSENSUS PAPER PREPARED BY THE LATIN AMERICAN ACADEMY FOR THE STUDY OF LIPIDS AND CARDIOMETABOLIC RISK (ALALIP) ENDORSED BY THE INTER-AMERICAN SOCIETY OF CARDIOLOGY (IASC) THE INTERNATIONAL ATHEROSCLEROSIS SOCIETY (IAS) AND THE PAN-AMERICAN COLLEGE OF ENDOTHELIUM (PACE). Año: 2021
• MEASURING AND PREDICTING PERSONAL AND HOUSEHOLD BLACK CARBON LEVELS FROM 88 COMMUNITIES IN EIGHT COUNTRIES. Año: 2021
• AMBULATORY PATIENTS WITH CARDIOMETABOLIC DISEASE AND WITHOUT EVIDENCE OF COVID-19 DURING THE PANDEMIC. THE CORCOVID LATAM STUDY. Año: 2021
• ERECTILE FUNCTION IN MEN WITH TYPE 2 DIABETES TREATED WITH DULAGLUTIDE: AN EXPLORATORY ANALYSIS OF THE REWIND PLACEBO-CONTROLLED RANDOMISED TRIAL. Año: 2021
• IMPACT OF OUTDOOR GYMS ON ADULTS' PARTICIPATION IN PHYSICAL ACTIVITY: A NATURAL EXPERIMENT IN CHILE. Año: 2021
• CARDIAC MYOSIN ACTIVATION WITH OMECAMTIV MECARBIL IN SYSTOLIC HEART FAILURE. Año: 2021
• POSITION STATEMENT ON USE OF PHARMACOLOGICAL COMBINATIONS IN A SINGLE PILL FOR TREATMENT OF HYPERTENSION BY ARGENTINE FEDERATION OF CARDIOLOGY (FAC) AND ARGENTINE SOCIETY OF HYPERTENSION (SAHA). Año: 2021
• UNDERSTANDING LIFE AND DEATH IN LATIN AMERICA Año: 2021 Link: https://doi.org/10.1038/s41591-021-01277-x
• GUIDELINES IN LOW AND MIDDLE INCOME COUNTRIES PAPER 1: SCOPING CLINICAL PRACTICE GUIDELINES IN CHILE AND THE PHILIPPINES. Año: 2021
• INFLUENZA VACCINATION FOR THE PREVENTION OF CARDIOVASCULAR DISEASE IN THE AMERICAS: CONSENSUS DOCUMENT OF THE INTER-AMERICAN SOCIETY OF CARDIOLOGY AND THE WORD HEART FEDERATION Año: 2021 Link: https://doi.org/10.5334/gh.1069
• ASSOCIATION OF BEDTIME WITH MORTALITY AND MAJOR CARDIOVASCULAR EVENTS: AN ANALYSIS OF 112198 INDIVIDUALS FROM 21 COUNTRIES IN THE PURE STUDY. Año: 2021
• AVAILABILITY AND AFFORDABILITY OF MEDICINES AND CARDIOVASCULAR OUTCOMES IN 21 HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES. Año: 2021
• ASSOCIATION BETWEEN DRINKING PATTERNS AND CARDIOVASCULAR RISK: A POPULATION-BASED STUDY IN THE SOUTHERN CONE OF LATIN AMERICA. Año: 2021
• SKELETONIZED VS PEDICLED INTERNAL MAMMARY ARTERY GRAFT HARVESTING IN CORONARY ARTERY BYPASS SURGERY: A POST HOC ANALYSIS FROM THE COMPASS TRIAL. Año: 2021
• SOTAGLIFLOZIN IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE. Año: 2021
• HOUSEHOLD COMMUNITY SUB-NATIONAL AND COUNTRY-LEVEL PREDICTORS OF PRIMARY COOKING FUEL SWITCHING IN NINE COUNTRIES FROM THE PURE STUDY. Año: 2021
• ATTRIBUTES OF THE FOOD AND PHYSICAL ACTIVITY BUILT ENVIRONMENTS FROM THE SOUTHERN CONE OF LATIN AMERICA. Año: 2021
• EFFECT OF DULAGLUTIDE ON COGNITIVE IMPAIRMENT IN TYPE 2 DIABETES: AN EXPLORATORY ANALYSIS OF THE REWIND TRIAL. Año: 2021
• ASSOCIATIONS OF CEREAL GRAINS INTAKE WITH CARDIOVASCULAR DISEASE AND MORTALITY ACROSS 21 COUNTRIES IN PROSPECTIVE URBAN AND RURAL EPIDEMIOLOGY STUDY: PROSPECTIVE COHORT STUDY. Año: 2021
• POSITION STATEMENT OF THE INTERAMERICAN SOCIETY OF CARDIOLOGY (IASC) ON THE CURRENT GUIDELINES FOR THE PREVENTION DIAGNOSIS AND TREATMENT OF ARTERIAL HYPERTENSION 2017-2020. Año: 2021
• SAFETY OF PROTON PUMP INHIBITORS BASED ON A LARGE MULTI-YEAR RANDOMIZED TRIAL OF PATIENTS RECEIVING RIVAROXABAN OR ASPIRIN. Año: 2021
• EFFECT OF SOTAGLIFLOZIN ON TOTAL HOSPITALIZATIONS IN PATIENTS WITH TYPE 2 DIABETES AND WORSENING HEART FAILURE : A RANDOMIZED TRIAL. Año: 2021
• VERICIGUAT IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION. Año: 2021
• SOTAGLIFLOZIN IN PATIENTS WITH DIABETES AND RECENT WORSENING HEART FAILURE. Año: 2021
• LONG-TERM EXPOSURE TO OUTDOOR AND HOUSEHOLD AIR POLLUTION AND BLOOD PRESSURE IN THE PROSPECTIVE URBAN AND RURAL EPIDEMIOLOGICAL (PURE) STUDY. Año: 2021
• SMOKING AND OBESITY IN CHILE'S THIRD NATIONAL HEALTH SURVEY: LIGHT AND SHADE. Año: 2021
• VARIATIONS IN COMMON DISEASES HOSPITAL ADMISSIONS AND DEATHS IN MIDDLE-AGED ADULTS IN 21 COUNTRIES FROM FIVE CONTINENTS (PURE): A PROSPECTIVE COHORT STUDY. Año: 2021
• URINARY SODIUM AND POTASSIUM AND RISK OF ISCHEMIC AND HEMORRHAGIC STROKE (INTERSTROKE): A CASE-CONTROL STUDY. Año: 2021
• A MULTINATIONAL REGISTRY TO STUDY THE CHARACTERISTICS AND OUTCOMES OF HEART FAILURE PATIENTS: THE GLOBAL CONGESTIVE HEART FAILURE (G-CHF) REGISTRY. Año: 2021
• MAY MEASUREMENT MONTH 2018: A PRAGMATIC GLOBAL SCREENING CAMPAIGN TO RAISE AWARENESS OF BLOOD PRESSURE BY THE INTERNATIONAL SOCIETY OF HYPERTENSION. Año: 2021
• INEQUALITIES IN THE USE OF SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE BY SOCIOECONOMIC STATUS: EVIDENCE FROM THE PURE OBSERVATIONAL STUDY. Año: 2021
• PANTOPRAZOLE TO PREVENT GASTRODUODENAL EVENTS IN PATIENTS RECEIVING RIVAROXABAN AND/OR ASPIRIN IN A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. Año: 2021
• VARIATIONS IN KNOWLEDGE AWARENESS AND TREATMENT OF HYPERTENSION AND STROKE RISK BY COUNTRY INCOME LEVEL. Año: 2021
• DIVERGING TRENDS IN OBESITY DIABETES AND RAISED BLOOD PRESSURE IN THE AMERICAS. Año: 2021
• THE AMERICAS: A REGION THAT AGES WITH DISPARITY. Año: 2021
• PREVALENCE AWARENESS TREATMENT AND CONTROL OF DIABETES AND IMPAIRED FASTING GLUCOSE IN THE SOUTHERN CONE OF LATIN AMERICA. Año: 2021
• EFFECT OF LORCASERIN ON PREVENTION AND REMISSION OF TYPE 2 DIABETES IN OVERWEIGHT AND OBESE PATIENTS (CAMELLIA-TIMI 61): A RANDOMISED PLACEBO-CONTROLLED TRIAL. Año: 2021
• MAY MEASUREMENT MONTH 2018: AN ANALYSIS OF BLOOD PRESSURE SCREENING RESULTS FROM CHILE. Año: 2021
• DULAGLUTIDE AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES (REWIND): A DOUBLE-BLIND RANDOMISED PLACEBO-CONTROLLED TRIAL. Año: 2021
• ASSOCIATION OF DAIRY INTAKE WITH CARDIOVASCULAR DISEASE AND MORTALITY IN 21 COUNTRIES FROM FIVE CONTINENTS (PURE): A PROSPECTIVE COHORT STUDY. Año: 2021
• PRACTICE PATTERNS AND OUTCOMES AFTER STROKE ACROSS COUNTRIES AT DIFFERENT ECONOMIC LEVELS (INTERSTROKE): AN INTERNATIONAL OBSERVATIONAL STUDY. Año: 2021
• ROLE OF COMBINATION ANTIPLATELET AND ANTICOAGULATION THERAPY IN DIABETES MELLITUS AND CARDIOVASCULAR DISEASE: INSIGHTS FROM THE COMPASS TRIAL. Año: 2021
• MAY MEASUREMENT MONTH 2017 IN CHILE-AMERICAS. Año: 2021
• IDEAL CARDIOVASCULAR HEALTH IN THE SOUTHERN CONE OFLATIN AMERICA. Año: 2021
• TOBACCO CONTROL ENVIRONMENT: CROSS-SECTIONAL SURVEY OF POLICY IMPLEMENTATION SOCIAL UNACCEPTABILITY KNOWLEDGE OF TOBACCO HEALTH HARMS AND RELATIONSHIP TO QUIT RATIO IN 17 LOW-INCOME MIDDLE-INCOME AND HIGH-INCOME COUNTRIES. Año: 2021
• EFFECTS OF ONCE-WEEKLY EXENATIDE ON CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES. Año: 2021
• PREVALENCE AWARENESS TREATMENT AND CONTROL OF HYPERTENSION IN RURAL AND URBAN COMMUNITIES IN LATIN AMERICAN COUNTRIES. Año: 2021
• RISK PROFILES AND ONE-YEAR OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN INDIA: INSIGHTS FROM THE GARFIELD-AF REGISTRY. Año: 2021
• FEATURES MANAGEMENT AND PROGNOSIS OF CHILEAN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION: GARFIELD AF REGISTRY. Año: 2021
• GLOBAL AND REGIONAL EFFECTS OF POTENTIALLY MODIFIABLE RISK FACTORS ASSOCIATED WITH ACUTE STROKE IN 32 COUNTRIES (INTERSTROKE): A CASE-CONTROL STUDY. Año: 2021
• BACTERIAL COMMUNITY PROFILE OF THE GUT MICROBIOTA DIFFERS BETWEEN HYPERCHOLESTEROLEMIC SUBJECTS AND CONTROLS. Año: 2021
• MORTALITY AND CARDIOVASCULAR AND RESPIRATORY MORBIDITY IN INDIVIDUALS WITH IMPAIRED FEV1 (PURE): AN INTERNATIONAL COMMUNITY-BASED COHORT STUDY. Año: 2021
• POLYMORPHISMS IN GENES INVOLVED IN THE LEPTIN-MELANOCORTIN PATHWAY ARE ASSOCIATED WITH OBESITY-RELATED CARDIOMETABOLIC ALTERATIONS IN A SOUTHERN CHILEAN POPULATION. Año: 2021
• LOWER TRACT RESPIRATORY INFECTION IN CHILDREN YOUNGER THAN 5YEARS OF AGE AND ADVERSE PREGNANCY OUTCOMES RELATED TO HOUSEHOLD AIR POLLUTION IN BARILOCHE (ARGENTINA) AND TEMUCO (CHILE). Año: 2021
• THE TECHNICAL REPORT ON SODIUM INTAKE AND CARDIOVASCULAR DISEASE IN LOW- AND MIDDLE-INCOME COUNTRIES BY THE JOINT WORKING GROUP OF THE WORLD HEART FEDERATION THE EUROPEAN SOCIETY OF HYPERTENSION AND THE EUROPEAN PUBLIC HEALTH ASSOCIATION. Año: 2021
• CLINICAL IMPACT OF THE POLYPILL FOR CARDIOVASCULAR PREVENTION IN LATIN AMERICA: A CONSENSUS STATEMENT OF THE INTER-AMERICAN SOCIETY OF CARDIOLOGY. Año: 2021
• ASSOCIATION OF DIETARY NUTRIENTS WITH BLOOD LIPIDS AND BLOOD PRESSURE IN 18 COUNTRIES: A CROSS-SECTIONAL ANALYSIS FROM THE PURE STUDY. Año: 2021
• THE CHANGING LANDSCAPE FOR STROKEPREVENTION IN AF: FINDINGS FROM THE GLORIA-AF REGISTRY PHASE 2. Año: 2021
• GENETIC AND NON-GENETIC DETERMINANTS OF CIRCULATING LEVELS OF ADIPONECTIN IN A COHORT OF CHILEAN SUBJECTS. Año: 2021
• ATRIAL FIBRILLATION AND THE DIRECT ANTICOAGULANTS. Año: 2021
• MAY MEASUREMENT MONTH 2017: AN ANALYSIS OF BLOOD PRESSURE SCREENING RESULTS WORLDWIDE. Año: 2021
• POLYPHARMACY AND EFFECTS OF APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION: POST HOC ANALYSIS OF THE ARISTOTLE TRIAL. Año: 2021
• EVALUATION OF THE QUALITY OF CLINICAL GUIDELINES FOR CARDIAC REHABILITATION: A CRITICAL REVIEW. Año: 2021
• HISTORY OF BLEEDING AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL. Año: 2021
• AVAILABILITY AND AFFORDABILITY OF BLOOD PRESSURE-LOWERING MEDICINES AND THE EFFECT ON BLOOD PRESSURE CONTROL IN HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES: AN ANALYSIS OF THE PURE STUDY DATA. Año: 2021
• INTERVAL TRAINING EXERCISE FOR HYPERTENSION Año: 2021
• RISK RELATED TO PRE-DIABETES MELLITUS AND DIABETES MELLITUS IN HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM PROSPECTIVE COMPARISON OF ARNI WITH ACEI TO DETERMINE IMPACT ON GLOBAL MORTALITY AND MORBIDITY IN HEART FAILURE TRIAL. Año: 2021
• EFFECTS OF BASAL INSULIN GLARGINE AND OMEGA-3 FATTY ACID ON COGNITIVE DECLINE AND PROBABLE COGNITIVE IMPAIRMENT IN PEOPLE WITH DYSGLYCAEMIA: A SUBSTUDY OF THE ORIGIN TRIAL. Año: 2021
• AVAILABILITY AND AFFORDABILITY OF CARDIOVASCULAR DISEASE MEDICINES AND THEIR EFFECT ON USE IN HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES: AN ANALYSIS OF THE PURE STUDY DATA. Año: 2021
• DESIGN AND BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE RESEARCHING CARDIOVASCULAR EVENTS WITH A WEEKLY INCRETIN IN DIABETES (REWIND) TRIAL ON THE CARDIOVASCULAR EFFECTS OF DULAGLUTIDE. Año: 2021
• ASSOCIATIONS OF URINARY SODIUM EXCRETION WITH CARDIOVASCULAR EVENTS IN INDIVIDUALS WITH AND WITHOUT HYPERTENSION: A POOLED ANALYSIS OF DATA FROM FOUR STUDIES. Año: 2021
• HEART FAILURE IN LOW- AND MIDDLE-INCOME COUNTRIES: BACKGROUND RATIONALE AND DESIGN OF THE INTERNATIONAL CONGESTIVE HEART FAILURE STUDY (INTER-CHF). Año: 2021
• EFFICACY SAFETY AND EFFECT ON BIOMARKERS RELATED TO CHOLESTEROL AND LIPOPROTEIN METABOLISM OF ROSUVASTATIN 10 OR 20 MG PLUS EZETIMIBE 10 MG VS. SIMVASTATIN 40 OR 80 MG PLUS EZETIMIBE 10 MG IN HIGH-RISK PATIENTS: RESULTS OF THE GRAVITY RANDOMIZED STUDY. Año: 2021
• RATIONALE DESIGN AND BASELINE CHARACTERISTICS IN EVALUATION OF LIXISENATIDE IN ACUTE CORONARY SYNDROME A LONG-TERM CARDIOVASCULAR END POINT TRIAL OF LIXISENATIDE VERSUS PLACEBO. Año: 2021
• EVOLOCUMAB AND CLINICAL OUTCOMES IN PATIENTS WITH CARDIOVASCULAR DISEASE. Año: 2021
• ASSOCIATION OF URINARY SODIUM EXCRETION WITH BLOOD PRESSURE AND CARDIOVASCULAR CLINICAL EVENTS IN 17033 LATIN AMERICANS. Año: 2021
• MULTIPLE CARDIOMETABOLIC RISK FACTORS IN THE SOUTHERN CONE OF LATIN AMERICA: A POPULATION-BASED STUDY IN ARGENTINA CHILE AND URUGUAY. Año: 2021
• LATIN AMERICAN CONSENSUS ON HYPERTENSION IN PATIENTS WITH DIABETES TYPE 2 AND METABOLIC SYNDROME. Año: 2021
• URINARY SODIUM AND POTASSIUM EXCRETION MORTALITY AND CARDIOVASCULAR EVENTS. Año: 2021
• SECONDARY CV PREVENTION IN SOUTH AMERICA IN A COMMUNITY SETTING: THE PURE STUDY. Año: 2021
• APIXABAN IN COMPARISON WITH WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: FINDINGS FROM THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION (ARISTOTLE) TRIAL. Año: 2021
• EFFICACY AND SAFETY OF RIVAROXABAN COMPARED WITH WARFARIN AMONG ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN THE RIVAROXABAN ONCE DAILY ORAL DIRECT FACTOR XA INHIBITION COMPARED WITH VITAMIN K ANTAGONISM FOR PREVENTION OF STROKE AND EMBOLISM TRIAL IN ATRIAL FIBRILLATION (ROCKET AF). Año: 2021
• RIVAROXABAN COMPARED WITH WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND PREVIOUS STROKE OR TRANSIENT ISCHAEMIC ATTACK: A SUBGROUP ANALYSIS OF ROCKET AF. Año: 2021
• ASSOCIATION OF POLYMORPHISMS WITHIN THE RENIN-ANGIOTENSIN SYSTEM WITH METABOLIC SYNDROME IN A COHORT OF CHILEAN SUBJECTS. Año: 2021
• PREVALENCE AWARENESS TREATMENT AND CONTROL OF HYPERTENSION IN RURAL AND URBAN COMMUNITIES IN HIGH- MIDDLE- AND LOW-INCOME COUNTRIES. Año: 2021
• ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITION COMPARED WITH ENALAPRIL ON THE RISK OF CLINICAL PROGRESSION IN SURVIVING PATIENTS WITH HEART FAILURE. Año: 2021
• USE OF SECONDARY PREVENTION DRUGS FOR CARDIOVASCULAR DISEASE IN THE COMMUNITY IN HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES (THE PURE STUDY): A PROSPECTIVE EPIDEMIOLOGICAL SURVEY. Año: 2021
• EFFECTS OF OFF-PUMP AND ON-PUMP CORONARY-ARTERY BYPASS GRAFTING AT 1 YEAR. Año: 2021
• ASSESSING GLOBAL RISK FACTORS FOR NON-FATAL INJURIES FROM ROAD TRAFFIC ACCIDENTS AND FALLS IN ADULTS AGED 35-70YEARS IN 17 COUNTRIES: A CROSS-SECTIONAL ANALYSIS OF THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGICAL (PURE) STUDY. Año: 2021
• MODIFICATION OF OUTCOMES WITH ASPIRIN OR APIXABAN IN RELATION TO CHADS(2) AND CHA(2)DS(2)-VASC SCORES IN PATIENTS WITH ATRIAL FIBRILLATION: A SECONDARY ANALYSIS OF THE AVERROES STUDY. Año: 2021
• PATTERNS OF ALCOHOL CONSUMPTION AND MYOCARDIAL INFARCTION RISK: OBSERVATIONS FROM 52 COUNTRIES IN THE INTERHEART CASE-CONTROL STUDY. Año: 2021
• DOUBLE-DOSE VERSUS STANDARD-DOSE CLOPIDOGREL AND HIGH-DOSE VERSUS LOW-DOSE ASPIRIN IN INDIVIDUALS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES (CURRENT-OASIS 7): A RANDOMISED FACTORIAL TRIAL. Año: 2021
• OFF-PUMP OR ON-PUMP CORONARY-ARTERY BYPASS GRAFTING AT 30 DAYS. Año: 2021
• EFFICACY OF EZETIMIBE IS NOT RELATED TO NPC1L1 GENE POLYMORPHISMS IN A PILOT STUDY OF CHILEAN HYPERCHOLESTEROLEMIC SUBJECTS. Año: 2021
• APIXABAN VERSUS ASPIRIN IN PATIENTS WITH ATRIAL FIBRILLATION AND PREVIOUS STROKE OR TRANSIENT ISCHAEMIC ATTACK: A PREDEFINED SUBGROUP ANALYSIS FROM AVERROES A RANDOMISED TRIAL. Año: 2021
• DETERIORATION OF KIDNEY FUNCTION AS A RISK FACTOR FOR MORTALITY AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE. Año: 2021
• EFFECT OF CLOPIDOGREL ADDED TO ASPIRIN IN PATIENTS WITH ATRIAL FIBRILLATION. Año: 2021
• RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION. Año: 2021
• EXERCISE FOR PEOPLE WITH HIGH CARDIOVASCULAR RISK. Año: 2021
• DETECTION AND FOLLOW-UP OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND RISK FACTORS IN THE SOUTHERN CONE OF LATIN AMERICA: THE PULMONARY RISK IN SOUTH AMERICA (PRISA) STUDY. Año: 2021
• CORONARY HEART DISEASE AND RISK FACTORS IN LATIN AMERICA Año: 2021 Link: https://doi.org/10.1016/j.gheart.2013.11.005
• SINGLE NUCLEOTIDE POLYMORPHISMS IN ABCG5 AND ABCG8 GENES IN CHILEAN SUBJECTS WITH POLYGENIC HYPERCHOLESTEROLEMIA AND CONTROLS. Año: 2021
• CLOPIDOGREL WITH OR WITHOUT OMEPRAZOLE IN CORONARY ARTERY DISEASE. Año: 2021
• VARIATIONS IN CAUSE AND MANAGEMENT OF ATRIAL FIBRILLATION IN A PROSPECTIVE REGISTRY OF 15400 EMERGENCY DEPARTMENT PATIENTS IN 46 COUNTRIES: THE RE-LY ATRIAL FIBRILLATION REGISTRY. Año: 2021
• DOSE COMPARISONS OF CLOPIDOGREL AND ASPIRIN IN ACUTE CORONARY SYNDROMES. Año: 2021
• RATIONALE AND DESIGN OF THE CORONARY ARTERY BYPASS GRAFTING SURGERY OFF OR ON PUMP REVASCULARIZATION STUDY: A LARGE INTERNATIONAL RANDOMIZED TRIAL IN CARDIAC SURGERY. Año: 2021
• PROSPECTIVE COMPARISON OF CLINICAL AND ECHOCARDIOGRAPHIC DIAGNOSIS OF RHEUMATIC CARDITIS: LONG TERM FOLLOW UP OF PATIENTS WITH SUBCLINICAL DISEASE. Año: 2021
• EARLY VERSUS DELAYED INVASIVE INTERVENTION IN ACUTE CORONARY SYNDROMES. Año: 2021
• PREVALENCE OF A HEALTHY LIFESTYLE AMONG INDIVIDUALS WITH CARDIOVASCULAR DISEASE IN HIGH- MIDDLE- AND LOW-INCOME COUNTRIES: THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. Año: 2021
• EFFECT OF DRONEDARONE ON CARDIOVASCULAR EVENTS IN ATRIAL FIBRILLATION. Año: 2021
• DETECTION AND FOLLOW-UP OF CARDIOVASCULAR DISEASE AND RISK FACTORS IN THE SOUTHERN CONE OF LATIN AMERICA: THE CESCAS I STUDY. Año: 2021
• EFFECTS OF RAMIPRIL AND ROSIGLITAZONE ON CARDIOVASCULAR AND RENAL OUTCOMES IN PEOPLE WITH IMPAIRED GLUCOSE TOLERANCE OR IMPAIRED FASTING GLUCOSE: RESULTS OF THE DIABETES REDUCTION ASSESSMENT WITH RAMIPRIL AND ROSIGLITAZONE MEDICATION (DREAM) TRIAL. Año: 2021
• PROGNOSIS AFTER MYOCARDIAL INFARCTION Año: 2021
• APIXABAN COMPARED WITH WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND PREVIOUS STROKE OR TRANSIENT ISCHAEMIC ATTACK: A SUBGROUP ANALYSIS OF THE ARISTOTLE TRIAL. Año: 2021
• -786T>C POLYMORPHISM OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE IN CHILEAN SUBJECTS WITH CORONARY ARTERY DISEASE AND CONTROLS. Año: 2021
• RISK FACTORS FOR ISCHAEMIC AND INTRACEREBRAL HAEMORRHAGIC STROKE IN 22 COUNTRIES (THE INTERSTROKE STUDY): A CASE-CONTROL STUDY. Año: 2021
• CHANGES IN THE PATTERNS OF DRUG PRESCRIPTION FOR ACUTE MYOCARDIAL INFARCT. COMPARISON OF 2 PERIODS. Año: 2021
• PATHOLOGY OF EXCISED CARDIAC VALVES: CORRELATION WITH CLINICAL FINDINGS (AUTHOR'S TRANSL) Año: 2021
• APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION. Año: 2021
• ASSOCIATION BETWEEN PREMATURITY AND MATERNAL ANEMIA IN VENEZUELAN PREGNANT WOMEN DURING THIRD TRIMESTER AT LABOR. Año: 2021
• FACTOR XII 46C --> T GENE POLYMORPHISM IN CHILEAN SUBJECTS WITH CORONARY ARTERY DISEASE AND CONTROLS. Año: 2021
• PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN TEMUCO CITY. Año: 2021
• LEVELS OF PHYSICAL ACTIVITY IN AN URBAN POPULATION FROM TEMUCO CHILE. Año: 2021
• VENTRICULAR RATE IN CARDIAC INSUFFICIENCY WITH ATRIAL FIBRILLATION AN ADEQUATE INDEX OF DIGITALIZATION?. Año: 2021
• RISK FACTORS FOR ACUTE MYOCARDIAL INFARCTION IN LATIN AMERICA: THE INTERHEART LATIN AMERICAN STUDY. Año: 2021
• CLINICAL AND HEMODYNAMIC EVALUATION OF ISOSORBIDE DINITRATE THERAPY IN HEART FAILURE (AUTHOR'S TRANSL). Año: 2021
• ABSTRACT: P885 GENETIC POLYMORPHISMS OF APOA5 ARE ASSOCIATED WITH HYPERTRIGLYCERIDEMIA AND HYPERGLYCEMIA IN CHILEAN SUBJECTS WITH CAD Año: 2021 Link: https://doi.org/10.1016/s1567-5688(09)71006-2
• ACUTE MYOCARDIAL INFARCTION IN CHILEAN HOSPITALS. FINAL RESULTS OF THE GEMI STUDY. Año: 2021
• MEASUREMENT OF CARDIAC OUTPUT BY THERMODILUTION. CORRELATION WITH THE DIRECT FICK METHOD (AUTHOR'S TRANSL). Año: 2021
• LN-HOSPITAL MORTALITY AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ACCORDING TO REPERFUSION THERAPY. Año: 2021
• ECHOCARDIOGRAPHY IN BACTERIAL ENDOCARDITIS Año: 2021
• REDUCTION OF MYOCARDIAL INFARCTION MORTALITY IN CHILEAN HOSPITALS. Año: 2021
• MARFAN'S SYNDROME (AUTHOR'S TRANSL). Año: 2021
• PROGNOSIS IN PATIENTS WITH DIPHTHERIC MYOCARDITIS AND BRADYARRHYTHMIAS: ASSESSMENT OF RESULTS OF VENTRICULAR PACING. Año: 2021
• TREATMENT OF ADVANCED HEART FAILURE WITH HYDRALAZINE AND ISOSORBIDE DINITRATE (AUTHOR'S TRANSL). Año: 2021
• GENDER-RELATED DIFFERENCES IN THE IMPACT OF COVID-19 PANDEMIC IN CARDIOMETABOLIC PATIENTS IN LATIN AMERICA: THE CORCOVID LATAM GENDER SUB-STUDY Año: 2022 Link: https://doi.org/10.1016/j.cpcardiol.2021.101075
• CLINICAL OUTCOMES AND RESPONSE TO VERICIGUAT ACCORDING TO INDEX HEART FAILURE EVENT: INSIGHTS FROM THE VICTORIA TRIAL. Año: 2021
• RISK FACTORS FOR IN-HOSPITAL MORTALITY AFTER CORONARY ARTERY BYPASS GRAFTING IN COLOMBIA. Año: 2021
• HEALTH-RELATED QUALITY OF LIFE AND MORTALITY IN HEART FAILURE: THE GLOBAL CONGESTIVE HEART FAILURE STUDY OF 23 000 PATIENTS FROM 40 COUNTRIES. Año: 2021
• ASSOCIATIONS OF FISH CONSUMPTION WITH RISK OF CARDIOVASCULAR DISEASE AND MORTALITY AMONG INDIVIDUALS WITH OR WITHOUT VASCULAR DISEASE FROM 58 COUNTRIES. Año: 2021
• PROTECTIVE EFFECT OF PINOT NOIR POMACE EXTRACT AGAINST THE CYTOTOXICITY INDUCED BY POLYCYCLIC AROMATIC HYDROCARBONS ON ENDOTHELIAL CELLS. Año: 2021
• GLYCEMIC INDEX GLYCEMIC LOAD AND CARDIOVASCULAR DISEASE AND MORTALITY. Año: 2021
• WHITE RICE INTAKE AND INCIDENT DIABETES: A STUDY OF 132373 PARTICIPANTS IN 21 COUNTRIES. Año: 2021
• TOTAL CARDIOVASCULAR OR FATAL EVENTS IN PEOPLE WITH TYPE 2 DIABETES AND CARDIOVASCULAR RISK FACTORS TREATED WITH DULAGLUTIDE IN THE REWIND TRAIL: A POST HOC ANALYSIS. Año: 2021
• ASSOCIATION OF DAIRY CONSUMPTION WITH METABOLIC SYNDROME HYPERTENSION AND DIABETES IN 147812 INDIVIDUALS FROM 21 COUNTRIES. Año: 2021
• ASSOCIATIONS OF OUTDOOR FINE PARTICULATE AIR POLLUTION AND CARDIOVASCULAR DISEASE IN 157436 INDIVIDUALS FROM 21 HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES (PURE): A PROSPECTIVE COHORT STUDY. Año: 2021
• MODIFIABLE RISK FACTORS CARDIOVASCULAR DISEASE AND MORTALITY IN 155722 INDIVIDUALS FROM 21 HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES (PURE): A PROSPECTIVE COHORT STUDY. Año: 2021
• THE EFFECT OF DULAGLUTIDE ON STROKE: AN EXPLORATORY ANALYSIS OF THE REWIND TRIAL. Año: 2021
• HEALTH EFFECTS OF HOUSEHOLD SOLID FUEL USE: FINDINGS FROM 11 COUNTRIES WITHIN THE PROSPECTIVE URBAN AND RURAL EPIDEMIOLOGY STUDY. Año: 2021
• DULAGLUTIDE AND RENAL OUTCOMES IN TYPE 2 DIABETES: AN EXPLORATORY ANALYSIS OF THE REWIND RANDOMISED PLACEBO-CONTROLLED TRIAL. Año: 2021
• SUICIDAL IDEATION IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN A LARGE URBAN COHORT OF ADULTS IN THE SOUTHERN CONE OF LATIN AMERICA. Año: 2021
• SOCIOECONOMIC STATUS AND RISK OF CARDIOVASCULAR DISEASE IN 20 LOW-INCOME MIDDLE-INCOME AND HIGH-INCOME COUNTRIES: THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGIC (PURE) STUDY. Año: 2021
• GLOBAL PROSPECTIVE SAFETY ANALYSIS OFRIVAROXABAN. Año: 2021
• XANTUS-EL: A REAL-WORLD PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS TREATED WITH RIVAROXABAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN EASTERN EUROPE MIDDLE EAST AFRICA AND LATIN AMERICA. Año: 2021
• PROGNOSTIC VALIDATION OF A NON-LABORATORY AND A LABORATORY BASED CARDIOVASCULAR DISEASE RISK SCORE IN MULTIPLE REGIONS OF THE WORLD. Año: 2021
• DOES GREATER INDIVIDUAL SOCIAL CAPITAL IMPROVE THE MANAGEMENT OF HYPERTENSION? CROSS-NATIONAL ANALYSIS OF 61 229 INDIVIDUALS IN 21 COUNTRIES. Año: 2021
• CYP2C192 POLYMORPHISM IN CHILEAN PATIENTS WITH IN-STENT RESTENOSIS DEVELOPMENT AND CONTROLS. Año: 2021
• ASSOCIATIONS OF FATS AND CARBOHYDRATE INTAKE WITH CARDIOVASCULAR DISEASE AND MORTALITY IN 18 COUNTRIES FROM FIVE CONTINENTS (PURE): A PROSPECTIVE COHORT STUDY. Año: 2021
• CLINICAL PERSPECTIVE ON ANTIHYPERTENSIVE DRUG TREATMENT IN ADULTS WITH GRADE 1 HYPERTENSION AND LOW-TO-MODERATE CARDIOVASCULAR RISK: AN INTERNATIONAL EXPERT CONSULTATION. Año: 2021
• RATIONALE DESIGN AND BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE CARDIOVASCULAR OUTCOMES FOR PEOPLE USING ANTICOAGULATION STRATEGIES (COMPASS) TRIAL. Año: 2021
• LATIN AMERICAN CLINICAL EPIDEMIOLOGY NETWORK SERIES - PAPER 1: THE LATIN AMERICAN CLINICAL EPIDEMIOLOGY NETWORK LATINCLEN. Año: 2021
• PREVALENCE AWARENESS TREATMENT AND CONTROL OF HYPERTENSION IN THE SOUTHERN CONE OF LATIN AMERICA. Año: 2021
• VARIATIONS IN DIABETES PREVALENCE IN LOW- MIDDLE- AND HIGH-INCOME COUNTRIES: RESULTS FROM THE PROSPECTIVE URBAN AND RURAL EPIDEMIOLOGICAL STUDY. Año: 2021
• COMPARISON OF INTERNATIONAL NORMALIZED RATIO AUDIT PARAMETERS IN PATIENTS ENROLLED IN GARFIELD-AF AND TREATED WITH VITAMIN K ANTAGONISTS. Año: 2021
• EFFICACY AND SAFETY OF APIXABAN COMPARED WITH ASPIRIN IN THE ELDERLY: A SUBGROUP ANALYSIS FROM THE AVERROES TRIAL. Año: 2021
• BLOOD PRESSURE CONTROL AND RISK OF STROKE OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION (ARISTOTLE) TRIAL. Año: 2021
• DOES SEX AFFECT ANTICOAGULANT USE FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION? THE PROSPECTIVE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD-ATRIAL FIBRILLATION. Año: 2021
• EFFECT OF SITAGLIPTIN ON CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES. Año: 2021
• CARDIOVASCULAR RISK AND EVENTS IN 17 LOW- MIDDLE- AND HIGH-INCOME COUNTRIES. Año: 2021
• MANAGEMENT AND CLINICAL OUTCOMES IN PATIENTS TREATED WITH APIXABAN VS WARFARIN UNDERGOING PROCEDURES. Año: 2021
• RESPONSE TO LETTER REGARDING ARTICLE EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN AT DIFFERENT LEVELS OF PREDICTED INTERNATIONAL NORMALIZED RATIO CONTROL FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. Año: 2021
• CARDIOVASCULAR RISK FACTORS AMONG MALES IN 1989 AND 2011-12 IN A SOUTHERN CHILEAN CITY. Año: 2021
• DUAL ANGIOTENSIN RECEPTOR AND NEPRILYSIN INHIBITION AS AN ALTERNATIVE TO ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN PATIENTS WITH CHRONIC SYSTOLIC HEART FAILURE: RATIONALE FOR AND DESIGN OF THE PROSPECTIVE COMPARISON OF ARNI WITH ACEI TO DETERMINE IMPACT ON GLOBAL MORTALITY AND MORBIDITY IN HEART FAILURE TRIAL (PARADIGM-HF). Año: 2021
• UNIVERSAL HEALTH COVERAGE AND ACCOMPLISHMENT OF SECONDARY PREVENTION GOALS AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. Año: 2021
• N-3 FATTY ACIDS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DYSGLYCEMIA. Año: 2021
• APIXABAN FOR EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM. Año: 2021
• THE EFFECT OF CHROMOSOME 9P21 VARIANTS ON CARDIOVASCULAR DISEASE MAY BE MODIFIED BY DIETARY INTAKE: EVIDENCE FROM A CASE/CONTROL AND A PROSPECTIVE STUDY. Año: 2021
• DRONEDARONE IN HIGH-RISK PERMANENT ATRIAL FIBRILLATION. Año: 2021
• TP53 CODON 72 POLYMORPHISM IS ASSOCIATED WITH CORONARY ARTERY DISEASE IN CHILEAN SUBJECTS. Año: 2021
• GLUCOSE LEVELS ARE ASSOCIATED WITH CARDIOVASCULAR DISEASE AND DEATH IN AN INTERNATIONAL COHORT OF NORMAL GLYCAEMIC AND DYSGLYCAEMIC MEN AND WOMEN: THE EPIDREAM COHORT STUDY. Año: 2021
• POLIMORFISMO PRO72ARG DEL GEN TP53 SE ASOCIA A ENFERMEDAD CORONARIA EN INDIVIDUOS CHILENOS Año: 2021 Link: https://doi.org/10.4067/s0718-85602009000200002
• RATIONALE AND DESIGN OF INTERSTROKE: A GLOBAL CASE-CONTROL STUDY OF RISK FACTORS FOR STROKE. Año: 2021
• RIESGO INDIVIDUAL Y POBLACIONAL EN INFARTO AGUDO DEL MIOCARDIO: ESTUDIO INTERHEART CHILE Año: 2021 Link: https://doi.org/10.4067/s0034-98872008000500002
• EFFICACY OF THE I(F) CURRENT INHIBITOR IVABRADINE IN PATIENTS WITH CHRONIC STABLE ANGINA RECEIVING BETA-BLOCKER THERAPY: A 4-MONTH RANDOMIZED PLACEBO-CONTROLLED TRIAL. Año: 2021
• PREVALENCE OF RISK FACTORS TO CARDIOVASCULAR DISEASE IN GROUP OF CHILEAN EMPLOYEES. Año: 2021
• USEFULNESS OF THROMBOLYTIC THERAPY WITH LOW DOSES OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION. Año: 2021
• DIGOXIN IS EFFECTIVE IN TH TREATMENT OF PATIENTS WITH HEART FAILURE AND SINUS RHYTHM. Año: 2021
• VARIATION IN STATED MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN FIVE COUNTRIES. Año: 2021
• HEMODYNAMIC EFFECTS OF HYDRALAZINE AT REST AND DURING EXERCISE IN PATIENTS WITH CONGESTIVE HEART FAILURE (AUTHOR'S TRANSL). Año: 2021
• HEMODYNAMIC EFFECTS OF NIFEDIPINE IN ACUTE MYOCARDIAL INFARCTION. Año: 2021
• CARDIOVASCULAR INVOLVEMENT IN RHEUMATIC DISEASES (AUTHOR'S TRANSL). Año: 2021
• ASSOCIATION OF ULTRA-PROCESSED FOOD INTAKE WITH RISK OF INFLAMMATORY BOWEL DISEASE: PROSPECTIVE COHORT STUDY. Año: 2021
• FIVE-YEAR OUTCOMES AFTER OFF-PUMP OR ON-PUMP CORONARY-ARTERY BYPASS GRAFTING. Año: 2021
• SIMILAR CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED OR HIGH RISK FOR CORONARY VASCULAR DISEASE TREATED WITH DULAGLUTIDE WITH AND WITHOUT BASELINE METFORMIN. Año: 2021
• CARDIOVASCULAR AND RENAL OUTCOMES WITH EFPEGLENATIDE IN TYPE 2 DIABETES. Año: 2021
• REFERENCE RANGES OF HANDGRIP STRENGTH FROM 125462 HEALTHY ADULTS IN 21 COUNTRIES: A PROSPECTIVE URBAN RURAL EPIDEMIOLOGIC (PURE) STUDY. Año: 2021
• CAUSE OF DEATH AND PREDICTORS OF ALL-CAUSE MORTALITY IN ANTICOAGULATED PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: DATA FROM ROCKET AF. Año: 2021
• GLOBAL VARIATIONS IN THE PREVALENCE TREATMENT AND IMPACT OF ATRIAL FIBRILLATION IN A MULTI-NATIONAL COHORT OF 153152 MIDDLE-AGED INDIVIDUALS. Año: 2021
• PREVALENCE PATTERNS AND CORRELATES OF PHYSICAL ACTIVITY AMONG THE ADULT POPULATION IN LATIN AMERICA: CROSS-SECTIONAL RESULTS FROM THE CESCAS I STUDY. Año: 2021
• MAY MEASUREMENT MONTH 2019: BLOOD PRESSURE SCREENING RESULTS FROM CHILE. Año: 2021
• RENAL IMPAIRMENT AND RISK OF ACUTE STROKE: THE INTERSTROKE STUDY. Año: 2021
• EFFECTIVE UNIVERSAL HEALTH COVERAGE AND IMPROVED 1-YEAR SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION: THE CHILEAN EXPERIENCE. Año: 2021
• HEART FAILURE IN AFRICA ASIA THE MIDDLE EAST AND SOUTH AMERICA: THE INTER-CHF STUDY. Año: 2021
• ADHERENCE TO DRINKING GUIDELINES AND REASONS FOR ALCOHOL CONSUMPTION CESSATION IN THE SOUTHERN CONE OF LATIN AMERICA - FINDINGS FROM THE CESCAS STUDY. Año: 2021
• LIXISENATIDE IN PATIENTS WITH TYPE 2 DIABETES AND ACUTE CORONARY SYNDROME. Año: 2021
• FACING THE STROKE BURDEN WORLDWIDE. Año: 2021
• PROGNOSTIC VALUE OF GRIP STRENGTH: FINDINGS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. Año: 2021
• LONG-TERM USE OF TICAGRELOR IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION. Año: 2021
• CONTRASTING ASSOCIATIONS BETWEEN DIABETES AND CARDIOVASCULAR MORTALITY RATES IN LOW- MIDDLE- AND HIGH-INCOME COUNTRIES: COHORT STUDY DATA FROM 143567 INDIVIDUALS IN 21 COUNTRIES IN THE PURE STUDY. Año: 2021
• COCHRANE CORNER: EXERCISE FOR PEOPLE WITH HIGH CARDIOVASCULAR RISK. Año: 2021
• HOUSEHOLD AND PERSONAL AIR POLLUTION EXPOSURE MEASUREMENTS FROM 120 COMMUNITIES IN EIGHT COUNTRIES: RESULTS FROM THE PURE-AIR STUDY. Año: 2021
• CIRCULATING MIRNA-23B AND MIRNA-143 ARE POTENTIAL BIOMARKERS FOR IN-STENT RESTENOSIS. Año: 2021
• ANGIOTENSIN-NEPRILYSIN INHIBITION VERSUS ENALAPRIL IN HEART FAILURE. Año: 2021
• ASSOCIATION OF URINARY SODIUM AND POTASSIUM EXCRETION WITH BLOOD PRESSURE. Año: 2021
• MAY MEASUREMENT MONTH 2017: LATIN AMERICA. Año: 2021
• CARDIOVASCULAR DISEASE IN LATIN AMERICA: THE GROWING EPIDEMIC. Año: 2021
• MAY MEASUREMENT MONTH 2019: THE GLOBAL BLOOD PRESSURE SCREENING CAMPAIGN OF THE INTERNATIONAL SOCIETY OF HYPERTENSION. Año: 2021
• VARIATIONS BETWEEN WOMEN AND MEN IN RISK FACTORS TREATMENTS CARDIOVASCULAR DISEASE INCIDENCE AND DEATH IN 27 HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES (PURE): A PROSPECTIVE COHORT STUDY. Año: 2021
• EVALUATION OF THE QUALITY OF CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF ESOPHAGEAL OR GASTRIC VARICEAL BLEEDING. Año: 2021
• BASELINE FEATURES OF THE VICTORIA (VERICIGUAT GLOBAL STUDY IN SUBJECTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION) TRIAL. Año: 2021
• THE ASSOCIATION BETWEEN OWNERSHIP OF COMMON HOUSEHOLD DEVICES AND OBESITY AND DIABETES IN HIGH MIDDLE AND LOW INCOME COUNTRIES. Año: 2021
• REGIONAL VARIATION IN CLINICAL CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: FINDINGS FROM THE ARISTOTLE TRIAL. Año: 2021
• HYBRID CARDIAC REHABILITATION TRIAL (HYCARET): PROTOCOL OF A RANDOMISED MULTICENTRE NON-INFERIORITY TRIAL IN SOUTH AMERICA. Año: 2021
• APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO PRIOR WARFARIN USE: RESULTS FROM THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL. Año: 2021
• PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY: BASELINE CHARACTERISTICS OF THE HOUSEHOLD SAMPLE AND COMPARATIVE ANALYSES WITH NATIONAL DATA IN 17 COUNTRIES. Año: 2021
• LATIN AMERICAN CONSENSUS ON THE MANAGEMENT OF HYPERTENSION IN THE PATIENT WITH DIABETES AND THE METABOLIC SYNDROME. Año: 2021
• EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN AT DIFFERENT LEVELS OF PREDICTED INTERNATIONAL NORMALIZED RATIO CONTROL FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. Año: 2021
• CHANGE IN THE DIAGNOSTIC THRESHOLD OF ARTERIAL HYPERTENSION IN LATIN AMERICA. Año: 2021
• COST-EFFECTIVENESS OF EXERCISE-BASED CARDIAC REHABILITATION IN CHILEAN PATIENTS SURVIVING ACUTE CORONARY SYNDROME. Año: 2021
• RELATIVE VALIDITY OF AN FFQ TO ESTIMATE DAILY FOOD AND NUTRIENT INTAKES FOR CHILEAN ADULTS. Año: 2021
• EFFICACY OF APIXABAN WHEN COMPARED WITH WARFARIN IN RELATION TO RENAL FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL. Año: 2021
• JOINT ASSOCIATION OF URINARY SODIUM AND POTASSIUM EXCRETION WITH CARDIOVASCULAR EVENTS AND MORTALITY: PROSPECTIVE COHORT STUDY. Año: 2021
• BASAL INSULIN AND CARDIOVASCULAR AND OTHER OUTCOMES IN DYSGLYCEMIA. Año: 2021
• ASSOCIATION BETWEEN MAPUCHE ETHNICITY AND STROKE: A CASE-CONTROL STUDY. Año: 2021
• THE CURRENT STATE OF MICRORNAS AS RESTENOSIS BIOMARKERS. Año: 2021
• ENOXAPARIN FOLLOWED BY ONCE-WEEKLY IDRABIOTAPARINUX VERSUS ENOXAPARIN PLUS WARFARIN FOR PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM: A RANDOMISED DOUBLE-BLIND DOUBLE-DUMMY NON-INFERIORITY TRIAL. Año: 2021
• RIVAROXABAN IN PATIENTS WITH A RECENT ACUTE CORONARY SYNDROME. Año: 2021
• AVAILABILITY AND AFFORDABILITY OF ESSENTIAL MEDICINES FOR DIABETES ACROSS HIGH-INCOME MIDDLE-INCOME AND LOW-INCOME COUNTRIES: A PROSPECTIVE EPIDEMIOLOGICAL STUDY. Año: 2021
• DESIGN HISTORY AND RESULTS OF THE THIAZOLIDINEDIONE INTERVENTION WITH VITAMIN D EVALUATION (TIDE) RANDOMISED CONTROLLED TRIAL. Año: 2021
• CARDIOVASCULAR SAFETY OF LORCASERIN IN OVERWEIGHT OR OBESE PATIENTS. Año: 2021
• URINARY SODIUM EXCRETION BLOOD PRESSURE CARDIOVASCULAR DISEASE AND MORTALITY: A COMMUNITY-LEVEL PROSPECTIVE EPIDEMIOLOGICAL COHORT STUDY. Año: 2021
• RADIAL VERSUS FEMORAL ACCESS FOR CORONARY ANGIOGRAPHY AND INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROMES (RIVAL): A RANDOMISED PARALLEL GROUP MULTICENTRE TRIAL. Año: 2021
• IRBESARTAN IN PATIENTS WITH ATRIAL FIBRILLATION. Año: 2021
• ESTIMATING PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE SOUTHERN CONE OF LATIN AMERICA: HOW DIFFERENT SPIROMETRIC CRITERIA MAY AFFECT DISEASE BURDEN AND HEALTH POLICIES. Año: 2021
• APIXABAN IN PATIENTS WITH ATRIAL FIBRILLATION. Año: 2021
• RIVAROXABAN WITH OR WITHOUT ASPIRIN IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: AN INTERNATIONAL RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. Año: 2021
• EFFECTIVENESS AND SAFETY OF ORAL ANTICOAGULATION TREATMENT WITH ACENOCOUMAROL IN NON-VALVULAR ATRIAL FIBRILLATION. Año: 2021
• INFLUENCE OF AMERINDIAN MITOCHONDRIAL DNA HAPLOGROUPS ON THROMBOSIS SUSCEPTIBILITY AND FREQUENCY OF FOUR GENETIC PROTHROMBOTIC VARIANTS IN SOUTHERN CHILEAN SUBJECTS. Año: 2021
• EFFECTS OF HIGH-DOSE VERSUS LOW-DOSE LOSARTAN ON CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE (HEAAL STUDY): A RANDOMISED DOUBLE-BLIND TRIAL. Año: 2021
• DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN AFTER PCI IN ATRIAL FIBRILLATION. Año: 2021
• POLYMORPHISMS OF THE NOS3 GENE IN SOUTHERN CHILEAN SUBJECTS WITH CORONARY ARTERY DISEASE AND CONTROLS. Año: 2021
• FRUIT VEGETABLE AND LEGUME INTAKE AND CARDIOVASCULAR DISEASE AND DEATHS IN 18 COUNTRIES (PURE): A PROSPECTIVE COHORT STUDY. Año: 2021
• RIVAROXABAN WITH OR WITHOUT ASPIRIN IN STABLE CARDIOVASCULAR DISEASE. Año: 2021
• DESIGN AND RATIONALE OF CURRENT-OASIS 7: A RANDOMIZED 2 X 2 FACTORIAL TRIAL EVALUATING OPTIMAL DOSING STRATEGIES FOR CLOPIDOGREL AND ASPIRIN IN PATIENTS WITH ST AND NON-ST-ELEVATION ACUTE CORONARY SYNDROMES MANAGED WITH AN EARLY INVASIVE STRATEGY. Año: 2021
• THE IMPACT OF CHILEAN HEALTH REFORM IN THE MANAGEMENT AND MORTALITY OF ST ELEVATION MYOCARDIAL INFARCTION (STEMI) IN CHILEAN HOSPITALS. Año: 2021
• INDIVIDUAL AND POPULATION RISK IN ACUTE MYOCARDIAL INFARCTION: THE CHILEAN INTERHEART STUDY. Año: 2021
• DETERMINANTS AND GEOGRAPHICAL VARIATION IN THE DISTRIBUTION OF DEPRESSION IN THE SOUTHERN CONE OF LATIN AMERICA: A POPULATION-BASED SURVEY IN FOUR CITIES IN ARGENTINA CHILE AND URUGUAY. Año: 2021
• GLOBAL MORTALITY VARIATIONS IN PATIENTS WITH HEART FAILURE: RESULTS FROM THE INTERNATIONAL CONGESTIVE HEART FAILURE (INTER-CHF) PROSPECTIVE COHORT STUDY. Año: 2021
• EFFECT OF RAMIPRIL ON THE INCIDENCE OF DIABETES. Año: 2021
• RATIONALE AND DESIGN OF ACTIVE: THE ATRIAL FIBRILLATION CLOPIDOGREL TRIAL WITH IRBESARTAN FOR PREVENTION OF VASCULAR EVENTS. Año: 2021
• WEALTH AND CARDIOVASCULAR HEALTH: A CROSS-SECTIONAL STUDY OF WEALTH-RELATED INEQUALITIES IN THE AWARENESS TREATMENT AND CONTROL OF HYPERTENSION IN HIGH- MIDDLE- AND LOW-INCOME COUNTRIES. Año: 2021
• EFFECT OF POTENTIALLY MODIFIABLE RISK FACTORS ASSOCIATED WITH MYOCARDIAL INFARCTION IN 52 COUNTRIES (THE INTERHEART STUDY): CASE-CONTROL STUDY. Año: 2021
• SERUM LIPIDS AND BLOOD PRESSURE LEVELS IN THE +MAPUCHE POPULATION LIVING IN THE CHILEAN REGION OF ARAUCANÍA. Año: 2021
• COMPARISON OF THE EFFECTS OF DIGOXIN OR ENALAPRIL IN THE TREATMENT OF HEART FAILURE DUE TO MITRAL INSUFFICIENCY. Año: 2021
• COMPARISON BETWEEN DIGOXIN AND ATENOLOL IN CHRONIC ATRIAL FIBRILLATION. Año: 2021
• HYDRALAZINE IN PATIENTS WITH SEVERE AORTIC INSUFFICIENCY. EFFECT ON VENTRICULAR PRESSURE AND VOLUME. Año: 2021
• PROGRAM FOR THE PREVENTION OF RECURRENCE IN RHEUMATIC DISEASES (REGION IX CHILE). Año: 2021
• CONTRAST ECHOCARDIOGRAPHY IN THE DIAGNOSIS OF ATRIAL SEPTAL DEFECT (AUTHOR'S TRANSL) Año: 2021
• POSTURAL HYPOTENSION IN DIABETIC PATIENTS (AUTHOR'S TRANSL) Año: 2021
• SODIUM RESTRICTION IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS Autores: Eloisa Colin-Ramirez;Nariman Sepehrvand;Sarah Rathwell;Heather Ross;Jorge Escobedo;Peter Macdonald;Richard Troughton;Clara Saldarriaga;Fernando Lanas;Robert Doughty;Finlay A. McAlister;Justin A. Ezekowitz; Año: 2023 Link: https://doi.org/10.1161/CIRCHEARTFAILURE.122.009879
• DULAGLUTIDE AND CARDIOVASCULAR AND HEART FAILURE OUTCOMES IN PATIENTS WITH AND WITHOUT HEART FAILURE: A POSTHOC ANALYSIS FROM THE REWIND RANDOMIZED TRIAL Autores: Kelley R.H. Branch;Gilles R. Dagenais;Alvaro Avezum;Jan Basile;Ignacio Conget;William C. Cushman;Petr Jansky;Mark Lakshmanan;Fernando Lanas;Lawrence A. Leiter;Prem Pais;Nana Pogosova;Peter J. Raubenheimer;Lars Ryden;Jonathan E. Shaw;Wayne H.H. Sheu;Theodora TemelkovaKurktschiev;M. Angelyn Bethel;Hertzel C. Gerstein;Ramasundarahettige Chinthanie;Jeffrey L. Probstfield; Año: 2022 Link: https://doi.org/10.1002/ejhf.2670